Eris Lifesciences Reappoints MD And Wholetime Directors For New Five-Year Terms

Eris Lifesciences Ltd. has reappointed Amit Indubhushan Bakshi as managing director for a five-year term beginning April 1, 2026, the company said in an exchange filing on Monday.

The board has also cleared the reappointment of wholetime directors Inderjeet Singh Negi, Kaushal Kamlesh Shah, and Krishnakumar Vaidyanathan for five-year terms. Shah’s new tenure will start from October 1, Negi’s from April 1, 2026, and Vaidyanathan’s from September 1, 2026.